Testing effectiveness (Phase 2)UnknownNCT01874743
What this trial is testing
Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
Who this might be right for
HIV-1 Infection
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 40